Sanggenon C decreases tumor cell viability associated with proteasome inhibition

Hongbiao Huang, Ningning Liu, Kai Zhao, Chenchen Zhu, Xiaoyu Lu, Shujue Li, Wen Lian, Ping Zhou, Xiaoxian Dong, Canguo Zhao, Haiping Guo, Change Zhang, Changshan Yang, Guanmei Wen, Li Lu, Xiaofen Li, Lixia Guan, Chunjiao Liu, Xuejun Wang, Qing Ping DouJinbao Liu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Several flavonoids have been reported to be proteasome inhibitors, but whether prenylated flavonoids are able to inhibit proteasome function remains unknown. We report for the first time that Sanggenon C, a natural prenylated flavonoid, inhibits tumor cellular proteasomal activity and cell viability. We found that (1) Sanggenon C inhibited tumor cell viability and induced cell cycle arrest at G0/G1 phase; (2) Sanggenon C inhibited the chymotrypsin-like activity of purified human 20S proteasome and 26S proteasome in H22 cell lysate, and Sanggenon C was able to dose-dependently accumulate ubiquitinated proteins and proteasome substrate protein p27; (3) Sanggenon C-induced proteasome inhibition occurred prior to cell death in murine H22 and P388 cell lines; (4) Sanggenon C induced death of human K562 cancer cells and primary cells isolated from leukemic patients. We conclude that Sanggenon C inhibits tumor cell viability via induction of cell cycle arrest and cell death, which is associated with its ability to inhibit the proteasome function and that proteasome inhibition by Sanggenon C at least partially contributes to the observed tumor cell growth-inhibitory activity.

Original languageEnglish (US)
Pages (from-to)1315-1325
Number of pages11
JournalFrontiers in Bioscience - Elite
Volume3 E
Issue number4
StatePublished - Jan 6 2011

Fingerprint

Proteasome Endopeptidase Complex
Tumors
Cell Survival
Cells
Neoplasms
Flavonoids
Cell death
Cell Cycle Checkpoints
Cell Death
Ubiquitinated Proteins
Cell Cycle Resting Phase
Proteasome Inhibitors
K562 Cells
sanggenone C
Chymotrypsin
G1 Phase
Cell growth
Human Activities
Cell Line
Substrates

Keywords

  • Cell cycle
  • Cell death
  • Flavonoid
  • Proteasome inhibitor
  • Sanggenon C

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Huang, H., Liu, N., Zhao, K., Zhu, C., Lu, X., Li, S., ... Liu, J. (2011). Sanggenon C decreases tumor cell viability associated with proteasome inhibition. Frontiers in Bioscience - Elite, 3 E(4), 1315-1325.

Sanggenon C decreases tumor cell viability associated with proteasome inhibition. / Huang, Hongbiao; Liu, Ningning; Zhao, Kai; Zhu, Chenchen; Lu, Xiaoyu; Li, Shujue; Lian, Wen; Zhou, Ping; Dong, Xiaoxian; Zhao, Canguo; Guo, Haiping; Zhang, Change; Yang, Changshan; Wen, Guanmei; Lu, Li; Li, Xiaofen; Guan, Lixia; Liu, Chunjiao; Wang, Xuejun; Dou, Qing Ping; Liu, Jinbao.

In: Frontiers in Bioscience - Elite, Vol. 3 E, No. 4, 06.01.2011, p. 1315-1325.

Research output: Contribution to journalArticle

Huang, H, Liu, N, Zhao, K, Zhu, C, Lu, X, Li, S, Lian, W, Zhou, P, Dong, X, Zhao, C, Guo, H, Zhang, C, Yang, C, Wen, G, Lu, L, Li, X, Guan, L, Liu, C, Wang, X, Dou, QP & Liu, J 2011, 'Sanggenon C decreases tumor cell viability associated with proteasome inhibition', Frontiers in Bioscience - Elite, vol. 3 E, no. 4, pp. 1315-1325.
Huang H, Liu N, Zhao K, Zhu C, Lu X, Li S et al. Sanggenon C decreases tumor cell viability associated with proteasome inhibition. Frontiers in Bioscience - Elite. 2011 Jan 6;3 E(4):1315-1325.
Huang, Hongbiao ; Liu, Ningning ; Zhao, Kai ; Zhu, Chenchen ; Lu, Xiaoyu ; Li, Shujue ; Lian, Wen ; Zhou, Ping ; Dong, Xiaoxian ; Zhao, Canguo ; Guo, Haiping ; Zhang, Change ; Yang, Changshan ; Wen, Guanmei ; Lu, Li ; Li, Xiaofen ; Guan, Lixia ; Liu, Chunjiao ; Wang, Xuejun ; Dou, Qing Ping ; Liu, Jinbao. / Sanggenon C decreases tumor cell viability associated with proteasome inhibition. In: Frontiers in Bioscience - Elite. 2011 ; Vol. 3 E, No. 4. pp. 1315-1325.
@article{f37e85e2fd0e48749718dccf3f7697e3,
title = "Sanggenon C decreases tumor cell viability associated with proteasome inhibition",
abstract = "Several flavonoids have been reported to be proteasome inhibitors, but whether prenylated flavonoids are able to inhibit proteasome function remains unknown. We report for the first time that Sanggenon C, a natural prenylated flavonoid, inhibits tumor cellular proteasomal activity and cell viability. We found that (1) Sanggenon C inhibited tumor cell viability and induced cell cycle arrest at G0/G1 phase; (2) Sanggenon C inhibited the chymotrypsin-like activity of purified human 20S proteasome and 26S proteasome in H22 cell lysate, and Sanggenon C was able to dose-dependently accumulate ubiquitinated proteins and proteasome substrate protein p27; (3) Sanggenon C-induced proteasome inhibition occurred prior to cell death in murine H22 and P388 cell lines; (4) Sanggenon C induced death of human K562 cancer cells and primary cells isolated from leukemic patients. We conclude that Sanggenon C inhibits tumor cell viability via induction of cell cycle arrest and cell death, which is associated with its ability to inhibit the proteasome function and that proteasome inhibition by Sanggenon C at least partially contributes to the observed tumor cell growth-inhibitory activity.",
keywords = "Cell cycle, Cell death, Flavonoid, Proteasome inhibitor, Sanggenon C",
author = "Hongbiao Huang and Ningning Liu and Kai Zhao and Chenchen Zhu and Xiaoyu Lu and Shujue Li and Wen Lian and Ping Zhou and Xiaoxian Dong and Canguo Zhao and Haiping Guo and Change Zhang and Changshan Yang and Guanmei Wen and Li Lu and Xiaofen Li and Lixia Guan and Chunjiao Liu and Xuejun Wang and Dou, {Qing Ping} and Jinbao Liu",
year = "2011",
month = "1",
day = "6",
language = "English (US)",
volume = "3 E",
pages = "1315--1325",
journal = "Frontiers in Bioscience - Elite",
issn = "1945-0494",
publisher = "Frontiers in Bioscience",
number = "4",

}

TY - JOUR

T1 - Sanggenon C decreases tumor cell viability associated with proteasome inhibition

AU - Huang, Hongbiao

AU - Liu, Ningning

AU - Zhao, Kai

AU - Zhu, Chenchen

AU - Lu, Xiaoyu

AU - Li, Shujue

AU - Lian, Wen

AU - Zhou, Ping

AU - Dong, Xiaoxian

AU - Zhao, Canguo

AU - Guo, Haiping

AU - Zhang, Change

AU - Yang, Changshan

AU - Wen, Guanmei

AU - Lu, Li

AU - Li, Xiaofen

AU - Guan, Lixia

AU - Liu, Chunjiao

AU - Wang, Xuejun

AU - Dou, Qing Ping

AU - Liu, Jinbao

PY - 2011/1/6

Y1 - 2011/1/6

N2 - Several flavonoids have been reported to be proteasome inhibitors, but whether prenylated flavonoids are able to inhibit proteasome function remains unknown. We report for the first time that Sanggenon C, a natural prenylated flavonoid, inhibits tumor cellular proteasomal activity and cell viability. We found that (1) Sanggenon C inhibited tumor cell viability and induced cell cycle arrest at G0/G1 phase; (2) Sanggenon C inhibited the chymotrypsin-like activity of purified human 20S proteasome and 26S proteasome in H22 cell lysate, and Sanggenon C was able to dose-dependently accumulate ubiquitinated proteins and proteasome substrate protein p27; (3) Sanggenon C-induced proteasome inhibition occurred prior to cell death in murine H22 and P388 cell lines; (4) Sanggenon C induced death of human K562 cancer cells and primary cells isolated from leukemic patients. We conclude that Sanggenon C inhibits tumor cell viability via induction of cell cycle arrest and cell death, which is associated with its ability to inhibit the proteasome function and that proteasome inhibition by Sanggenon C at least partially contributes to the observed tumor cell growth-inhibitory activity.

AB - Several flavonoids have been reported to be proteasome inhibitors, but whether prenylated flavonoids are able to inhibit proteasome function remains unknown. We report for the first time that Sanggenon C, a natural prenylated flavonoid, inhibits tumor cellular proteasomal activity and cell viability. We found that (1) Sanggenon C inhibited tumor cell viability and induced cell cycle arrest at G0/G1 phase; (2) Sanggenon C inhibited the chymotrypsin-like activity of purified human 20S proteasome and 26S proteasome in H22 cell lysate, and Sanggenon C was able to dose-dependently accumulate ubiquitinated proteins and proteasome substrate protein p27; (3) Sanggenon C-induced proteasome inhibition occurred prior to cell death in murine H22 and P388 cell lines; (4) Sanggenon C induced death of human K562 cancer cells and primary cells isolated from leukemic patients. We conclude that Sanggenon C inhibits tumor cell viability via induction of cell cycle arrest and cell death, which is associated with its ability to inhibit the proteasome function and that proteasome inhibition by Sanggenon C at least partially contributes to the observed tumor cell growth-inhibitory activity.

KW - Cell cycle

KW - Cell death

KW - Flavonoid

KW - Proteasome inhibitor

KW - Sanggenon C

UR - http://www.scopus.com/inward/record.url?scp=80053618187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053618187&partnerID=8YFLogxK

M3 - Article

C2 - 21622138

AN - SCOPUS:80053618187

VL - 3 E

SP - 1315

EP - 1325

JO - Frontiers in Bioscience - Elite

JF - Frontiers in Bioscience - Elite

SN - 1945-0494

IS - 4

ER -